🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Calumet shares hold Buy rating with revised target amid SAF growth and DOE loan optimism

EditorAhmed Abdulazez Abdulkadir
Published 11/11/2024, 17:52
CLMT
-

On Monday (NASDAQ:MNDY), TD Cowen adjusted its outlook on Calumet Specialty Products (NASDAQ:CLMT) Partners, lowering the firm's price target on the stock to $26 from the previous $27 while maintaining a Buy rating. The revision reflects the analyst's perspective on the company's financial strategies and market conditions.

Calumet Specialty Products Partners, which trades on NASDAQ under the ticker NASDAQ:CLMT, has been assured of its confidence in securing loan funds from the Department of Energy (DOE) and has provided guidance on the utilization of these funds. The company has indicated that there is no current requirement for the issuance of additional equity.

The analyst highlighted that Calumet's Sustainable Aviation Fuel (SAF) is currently generating a significant premium over Renewable Diesel (RD). This performance supports the firm's positive stance on the stock, as it sees potential for long-term value stemming from Calumet's expansion into SAF and its efforts to reduce debt.

However, the analyst also pointed out that the margins for Renewable Diesel in the first half of 2025 could experience volatility. This potential instability is attributed to the absence of finalized regulations concerning the 45Z tax credit, which is anticipated to have a direct impact on the RD market.

The company's strategic focus on expanding its SAF segment and improving its financial leverage appears to underpin the continued Buy rating, despite the slight reduction in the price target. The outlook suggests that while near-term challenges exist, the long-term prospects for Calumet Specialty Products Partners remain favorable.

In other recent news, Calumet, Inc. reported strong performance and strategic advancements in their Q3 2024 earnings call. The company announced its successful conversion to a C-Corporation, a significant loan commitment from the Department of Energy for its Montana Renewables division, and record production volumes in its specialty products segment. Calumet also emphasized its growing role in the sustainable aviation fuel market, with plans to substantially increase production capacity by 2026.

Furthermore, Calumet secured a conditional $1.44 billion Department of Energy loan for the MaxSAF project expansion. The company reported $12.7 million in adjusted EBITDA for its renewable segment in Q3. This loan will be used to clear existing debt, fund current expenses, and finance the MaxSAF project.

However, a 30-day production outage is expected due to a catalyst change, which will affect fourth-quarter volumes. Despite this, the specialty products segment achieved record production volumes, with positive trends in specialty margins consistently between $60 and $70 per barrel.

Lastly, management expressed confidence in the future of the small refinery exemptions program and reassured investors of their legal position on SREs.

InvestingPro Insights

Recent data from InvestingPro sheds additional light on Calumet Specialty Products Partners' financial position and market performance. The company's market capitalization stands at $1.91 billion, reflecting its current valuation in the market. Despite the analyst's positive outlook, InvestingPro Tips highlight some challenges facing the company. For instance, Calumet operates with a significant debt burden and its short-term obligations exceed liquid assets, which could impact its financial flexibility as it pursues expansion in the SAF segment.

On a more positive note, Calumet has shown strong market performance, with a 63.05% price return over the last three months and a 48.37% return over the past year. This aligns with the analyst's confidence in the company's long-term value potential. However, investors should be aware that the company is not currently profitable, with a negative P/E ratio of -12.38 for the last twelve months as of Q3 2024.

For those seeking a more comprehensive analysis, InvestingPro offers 11 additional tips on Calumet Specialty Products Partners, providing deeper insights into the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.